Antimicrobial properties of perfusate fluid after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CS-HIPEC) with mitomycin C
Annals of Surgical Oncology Oct 14, 2017
Lange KN, et al. - In view of identifying fewer incisional infectious complications than expected after CS-HIPEC with mitomycin C (MMC), researchers investigated the antimicrobial properties of HIPEC perfusate fluid. They observed considerable antimicrobial properties of HIPEC perfusate. These antimicrobial properties varied between patients and were stronger against E. coli than against S. aureus. Further studies of HIPEC carrier solutions and chemotherapy agents could provide help in reduction of surgical-site infection and thus enhanced patient recovery.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries